On a mechanistic level, elevated DNMT expression [46,87,88,89,90] and increased global DNA methylation in peripheral blood and tumor tissue suggest a co-oncogenic role of methylation in retinoblastoma beyond RB1 mutations [26]. This evidence concerns the gene RB1 and retinoblastoma.